Ewha to transfer Anapa technology to Fresenius kabi AG.

Ewha pharmaceutical company agreed with Fresenius kabi AG, a german drug company to sell 25% of its equity under the conditions that Fresenius kabi AG would purchase additional stakes until 2009 and such investment should put into the facility automation projects.

The agreement was accomplished largely owing to Anapa technology and its brand value, a disposable drug infusion pump system, whi...